The Latest Breaking News from Obesity

Appetite suppressant Wegovy, popular with celebrities, seen as breakthrough treatment but not permanent remedy

A federal law that boosted nutrition standards for school meals may have begun to help slow the rise in obesity among America's children

A recent study discovered a relationship between neurodegeneration and Alzheimer's disease (AD) patients, meaning that losing weight could minimise cognitive decline and cut the prevalence of AD.

A recent study discovered a relationship between neurodegeneration and Alzheimer's disease (AD) patients, meaning that losing weight could minimise cognitive decline and cut the prevalence of AD. Read further on Dynamite News:

Sales of the buzzy new class of diabetes drugs have skyrocketed more than 2,000% in 4 years, data from Komodo Health shows.

Work is continuing on a Joint Health and Wellbeing Strategy for Nottingham, one of the main focuses of which is reducing the city's obesity levels.

Director Darren Aronofsky spent years searching for someone to play the English teacher with severe obesity at the centre of his film. But the film has been accused of fatphobia.

Prominent pharma player Novo Nordisk (NVO) posted solid revenue and earnings growth in fiscal 2022. The company’s long-term growth is expected to be spearheaded by its immensely popular GLP-1 drug Wegovy. Given the potential of its current portfolio of drugs and drugs under research, investing in this stock could be…

Children’s minister Claire Coutinho warned on Thursday against “pussyfooting” around dealing with England’s obesity crisis among youngsters.

The chemicals have also been linked to cancer, early menopause, obesity and infertility

A new study finds changes in the brain associated with obesity overlap with similar patterns seen in Alzheimer's disease.